dalteparin has been researched along with Hyperpotassemia in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Hyperkalemia is an infrequent but potentially serious complication of low molecular weight heparin (LMWH) use." | 2.79 | Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease--a post-hoc analysis of the PARAT trial. ( Bramlage, P; Melzer, N; Michaelis, HC, 2014) |
"The cause of hyperkalemia is frequently iatrogenic." | 1.72 | [Hyperkalemia due to low-molecular-weight heparin]. ( Appelman-Dijkstra, NM; den Exter, PL; Koopman, JJEB; van der Heiden, W, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
van der Heiden, W | 1 |
Koopman, JJEB | 1 |
Appelman-Dijkstra, NM | 1 |
den Exter, PL | 1 |
Gheno, G | 1 |
Cinetto, L | 1 |
Savarino, C | 1 |
Vellar, S | 1 |
Carraro, M | 1 |
Randon, M | 1 |
Torres, OH | 1 |
Hernandez, N | 1 |
Francia, E | 1 |
Barcelo, M | 1 |
Mateo, J | 1 |
Ruiz, D | 1 |
Rocha, E | 1 |
Gómez-Outes, A | 1 |
Martínez González, J | 1 |
Kakkar, VV | 1 |
Danguy, C | 1 |
Biston, P | 1 |
Carlier, E | 1 |
Defrance, P | 1 |
Piagnerelli, M | 1 |
Koren-Michowitz, M | 1 |
Avni, B | 1 |
Michowitz, Y | 1 |
Moravski, G | 1 |
Efrati, S | 1 |
Golik, A | 1 |
Wiggam, MI | 1 |
Beringer, TR | 1 |
Melzer, N | 1 |
Bramlage, P | 1 |
Michaelis, HC | 1 |
Shimokaze, T | 1 |
Akaba, K | 1 |
Saito, E | 1 |
4 trials available for dalteparin and Hyperpotassemia
Article | Year |
---|---|
Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Enoxaparin; Female; Humans; Hyperkalemia; Logistic M | 2003 |
Effect of prophylactic treatment with low-molecular-weight heparin bemiparin sodium on serum potassium levels: a prospective observational study.
Topics: Aged; Female; Heparin, Low-Molecular-Weight; Humans; Hyperkalemia; Male; Potassium; Prospective Stud | 2010 |
Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study.
Topics: Aldosterone; Anticoagulants; Creatinine; Enoxaparin; Female; Humans; Hydrogen-Ion Concentration; Hyp | 2004 |
Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease--a post-hoc analysis of the PARAT trial.
Topics: Aged; Anticoagulants; Coronary Artery Disease; Double-Blind Method; Female; Heparin, Low-Molecular-W | 2014 |
5 other studies available for dalteparin and Hyperpotassemia
Article | Year |
---|---|
[Hyperkalemia due to low-molecular-weight heparin].
Topics: Anticoagulants; Heparin; Heparin, Low-Molecular-Weight; Humans; Hyperkalemia; Hypoaldosteronism; Mal | 2022 |
Effect of unfractionated heparin and long-term treatment with low-molecular-weight heparin, bemiparin, on potassium levels.
Topics: Anticoagulants; Heparin, Low-Molecular-Weight; Humans; Hyperkalemia; Potassium; Thrombosis | 2005 |
Severe hyperkalemia in critically ill patients treated with prophylactic doses of enoxaparin.
Topics: Aged; Enoxaparin; Female; Fibrinolytic Agents; Humans; Hyperkalemia; Intensive Care Units; Male; Mid | 2012 |
Effect of low-molecular-weight heparin on serum concentrations of potassium.
Topics: Aged; Aged, 80 and over; Anticoagulants; Enoxaparin; Female; Humans; Hyperkalemia | 1997 |
Heparin-induced hyperkalemia in an extremely-low-birth-weight infant: a case report.
Topics: Anticoagulants; Dalteparin; Female; Heparin; Humans; Hyperkalemia; Infant, Newborn; Infant, Very Low | 2014 |